|
Volumn 126, Issue 9, 2002, Pages 1106-1109
|
Primary yolk sac tumor of the urachus: Case report with immunohistochemical and flow cytometric studies
|
Author keywords
[No Author keywords available]
|
Indexed keywords
ALPHA FETOPROTEIN;
BLEOMYCIN;
CISPLATIN;
CYTOKERATIN;
DNA;
ETOPOSIDE;
PROTEIN MDM2;
PROTEIN P53;
TRYPSIN INHIBITOR;
ABDOMINAL DISTENSION;
ABDOMINAL MASS;
ABDOMINAL TUMOR;
ABDOMINAL WALL;
ADENOCARCINOMA;
ADJUVANT CHEMOTHERAPY;
ARTICLE;
CANCER SURGERY;
CELL CYCLE S PHASE;
CHEMOTHERAPY;
COMPUTER ASSISTED TOMOGRAPHY;
DIAGNOSTIC ERROR;
DIPLOIDY;
EMBRYONAL RHABDOMYOSARCOMA;
FLOW CYTOMETRY;
FOLLOW UP;
HEMOPERITONEUM;
HISTOLOGY;
HORMONE BLOOD LEVEL;
HUMAN;
HUMAN TISSUE;
IMMUNOHISTOCHEMISTRY;
INFANT;
MALE;
METASTASIS;
NECROSIS;
PERIPHERAL VEIN;
PHYSICAL EXAMINATION;
PROTEIN EXPRESSION;
TESTIS;
TUMOR CELL;
TUMOR VOLUME;
UMBILICAL VEIN;
UMBILICUS;
URACHUS;
VOMITING;
YOLK SAC TUMOR;
ALPHA 1-ANTITRYPSIN;
ALPHA-FETOPROTEINS;
ANTINEOPLASTIC COMBINED CHEMOTHERAPY PROTOCOLS;
BLEOMYCIN;
CHEMOTHERAPY, ADJUVANT;
CISPLATIN;
DNA, NEOPLASM;
ENDODERMAL SINUS TUMOR;
ETOPOSIDE;
FLOW CYTOMETRY;
HUMANS;
IMMUNOHISTOCHEMISTRY;
INFANT;
KERATINS;
MALE;
NUCLEAR PROTEINS;
PROTO-ONCOGENE PROTEINS;
PROTO-ONCOGENE PROTEINS C-MDM2;
TOMOGRAPHY, X-RAY COMPUTED;
TREATMENT OUTCOME;
TUMOR MARKERS, BIOLOGICAL;
URACHUS;
URINARY BLADDER NEOPLASMS;
|
EID: 0036770447
PISSN: 00039985
EISSN: None
Source Type: Journal
DOI: None Document Type: Article |
Times cited : (26)
|
References (10)
|